The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study

SIMPLE SUMMARY: Radium-223 is an alpha-emitting radioisotope that selectively binds to increased bone turnover areas, such as metastatic sites, acting as a bone-seeking calcium mimetic drug. Its therapeutic function in metastatic castration-resistant prostate cancer patients relies on its capability...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Bauckneht, Matteo, Rebuzzi, Sara Elena, Signori, Alessio, Donegani, Maria Isabella, Murianni, Veronica, Miceli, Alberto, Borea, Roberto, Raffa, Stefano, Damassi, Alessandra, Ponzano, Marta, Catalano, Fabio, Martelli, Valentino, Marini, Cecilia, Boccardo, Francesco, Morbelli, Silvia, Sambuceti, Gianmario, Fornarini, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693606/
https://ncbi.nlm.nih.gov/pubmed/33142739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113213
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares